U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Secondary hyperparathyroidism

MedGen UID:
9368
Concept ID:
C0020503
Disease or Syndrome
Synonyms: Hyperparathyroidism, Secondary; Hyperparathyroidisms, Secondary; Secondary Hyperparathyroidism; Secondary Hyperparathyroidisms
SNOMED CT: Secondary hyperparathyroidism (91478007)
 
HPO: HP:0000867
Monarch Initiative: MONDO:0006964

Definition

Secondary hyperparathyroidism refers to the production of higher than normal levels of parathyroid hormone in the presence of hypocalcemia. [from HPO]

Term Hierarchy

Conditions with this feature

Vitamin D-dependent rickets, type 1
MedGen UID:
124344
Concept ID:
C0268689
Disease or Syndrome
Vitamin D-dependent rickets is a disorder of bone development that leads to softening and weakening of the bones (rickets). There are several forms of the condition that are distinguished primarily by their genetic causes: type 1A (VDDR1A), type 1B (VDDR1B), and type 2A (VDDR2A). There is also evidence of a very rare form of the condition, called type 2B (VDDR2B), although not much is known about this form.\n\nThe signs and symptoms of vitamin D-dependent rickets begin within months after birth, and most are the same for all types of the condition. The weak bones often cause bone pain and delayed growth and have a tendency to fracture. When affected children begin to walk, they may develop abnormally curved (bowed) legs because the bones are too weak to bear weight. Impaired bone development also results in widening of the areas near the ends of bones where new bone forms (metaphyses), especially in the knees, wrists, and ribs. Some people with vitamin D-dependent rickets have dental abnormalities such as thin tooth enamel and frequent cavities. Poor muscle tone (hypotonia) and muscle weakness are also common in this condition, and some affected individuals develop seizures.\n\nIn vitamin D-dependent rickets, there is an imbalance of certain substances in the blood. An early sign in all types of the condition is low levels of the mineral calcium (hypocalcemia), which is essential for the normal formation of bones and teeth. Affected individuals also develop high levels of a hormone involved in regulating calcium levels called parathyroid hormone (PTH), which leads to a condition called secondary hyperparathyroidism. Low levels of a mineral called phosphate (hypophosphatemia) also occur in affected individuals. Vitamin D-dependent rickets types 1 and 2 can be grouped by blood levels of a hormone called calcitriol, which is the active form of vitamin D; individuals with VDDR1A and VDDR1B have abnormally low levels of calcitriol and individuals with VDDR2A and VDDR2B have abnormally high levels.\n\nHair loss (alopecia) can occur in VDDR2A, although not everyone with this form of the condition has alopecia. Affected individuals can have sparse or patchy hair or no hair at all on their heads. Some affected individuals are missing body hair as well.
Vitamin D-dependent rickets type II with alopecia
MedGen UID:
90989
Concept ID:
C0342646
Disease or Syndrome
Vitamin D-dependent rickets type 2A (VDDR2A) is caused by a defect in the vitamin D receptor gene. This defect leads to an increase in the circulating ligand, 1,25-dihydroxyvitamin D3. Most patients have total alopecia in addition to rickets. VDDR2B (600785) is a form of vitamin D-dependent rickets with a phenotype similar to VDDR2A but a normal vitamin D receptor, in which end-organ resistance to vitamin D has been shown to be caused by a nuclear ribonucleoprotein that interferes with the vitamin D receptor-DNA interaction. For a general phenotypic description and a discussion of genetic heterogeneity of rickets due to disorders in vitamin D metabolism or action, see vitamin D-dependent rickets type 1A (VDDR1A; 264700).

Professional guidelines

PubMed

Chen TK, Knicely DH, Grams ME
JAMA 2019 Oct 1;322(13):1294-1304. doi: 10.1001/jama.2019.14745. PMID: 31573641Free PMC Article
Mizobuchi M, Ogata H, Koiwa F
Ther Apher Dial 2019 Aug;23(4):309-318. Epub 2018 Dec 18 doi: 10.1111/1744-9987.12772. PMID: 30411503
Lau WL, Obi Y, Kalantar-Zadeh K
Clin J Am Soc Nephrol 2018 Jun 7;13(6):952-961. Epub 2018 Mar 9 doi: 10.2215/CJN.10390917. PMID: 29523679Free PMC Article

Recent clinical studies

Etiology

Egan CE, Qazi M, Lee J, Lee-Saxton YJ, Greenberg JA, Beninato T, Zarnegar R, Fahey TJ 3rd, Finnerty BM
J Surg Res 2023 Nov;291:330-335. Epub 2023 Jul 26 doi: 10.1016/j.jss.2023.06.031. PMID: 37506432
Brandenburg V, Ketteler M
Nutrients 2022 Jul 22;14(15) doi: 10.3390/nu14153009. PMID: 35893866Free PMC Article
Komaba H, Hamano T, Fujii N, Moriwaki K, Wada A, Masakane I, Nitta K, Fukagawa M
J Clin Endocrinol Metab 2022 Jun 16;107(7):2016-2025. doi: 10.1210/clinem/dgac142. PMID: 35277957
Rroji M, Spasovski G
Int Urol Nephrol 2018 Jul;50(7):1271-1275. Epub 2018 Mar 12 doi: 10.1007/s11255-018-1838-5. PMID: 29532306
Lau WL, Obi Y, Kalantar-Zadeh K
Clin J Am Soc Nephrol 2018 Jun 7;13(6):952-961. Epub 2018 Mar 9 doi: 10.2215/CJN.10390917. PMID: 29523679Free PMC Article

Diagnosis

Hiramitsu T, Hasegawa Y, Futamura K, Okada M, Goto N, Narumi S, Watarai Y, Tominaga Y, Ichimori T
Front Endocrinol (Lausanne) 2023;14:1169793. Epub 2023 Apr 20 doi: 10.3389/fendo.2023.1169793. PMID: 37152972Free PMC Article
Sell J, Ramirez S, Partin M
Am Fam Physician 2022 Mar 1;105(3):289-298. PMID: 35289573
Messa P, Alfieri CM
Front Horm Res 2019;51:91-108. Epub 2018 Nov 19 doi: 10.1159/000491041. PMID: 30641516
Mizobuchi M, Ogata H, Koiwa F
Ther Apher Dial 2019 Aug;23(4):309-318. Epub 2018 Dec 18 doi: 10.1111/1744-9987.12772. PMID: 30411503
Jamal SA, Miller PD
J Clin Densitom 2013 Jan-Mar;16(1):64-8. Epub 2012 Dec 23 doi: 10.1016/j.jocd.2012.11.012. PMID: 23267748

Therapy

Hiramitsu T, Hasegawa Y, Futamura K, Okada M, Goto N, Narumi S, Watarai Y, Tominaga Y, Ichimori T
Front Endocrinol (Lausanne) 2023;14:1169793. Epub 2023 Apr 20 doi: 10.3389/fendo.2023.1169793. PMID: 37152972Free PMC Article
Ogata H, Fukagawa M, Hirakata H, Kagimura T, Fukushima M, Akizawa T; LANDMARK Investigators and Committees
JAMA 2021 May 18;325(19):1946-1954. doi: 10.1001/jama.2021.4807. PMID: 34003226Free PMC Article
Reiss AB, Miyawaki N, Moon J, Kasselman LJ, Voloshyna I, D'Avino R Jr, De Leon J
Atherosclerosis 2018 Nov;278:49-59. Epub 2018 Aug 30 doi: 10.1016/j.atherosclerosis.2018.08.046. PMID: 30253289
Jean G, Souberbielle JC, Chazot C
Nutrients 2017 Mar 25;9(4) doi: 10.3390/nu9040328. PMID: 28346348Free PMC Article
Block GA, Bushinsky DA, Cheng S, Cunningham J, Dehmel B, Drueke TB, Ketteler M, Kewalramani R, Martin KJ, Moe SM, Patel UD, Silver J, Sun Y, Wang H, Chertow GM
JAMA 2017 Jan 10;317(2):156-164. doi: 10.1001/jama.2016.19468. PMID: 28097356

Prognosis

Salman MA, Salman A, Elewa A, Rabiee A, Tourky M, Shaaban HE, Issa M, AbdAlla A, Khattab M, Refaat A, Fathy E, Mohamed US, Noureldin K, Moustafa A, Elias AA, Elmarzouky MS, Shazly MN, Omar HSE
Obes Surg 2022 Apr;32(4):1141-1148. Epub 2022 Jan 20 doi: 10.1007/s11695-022-05902-7. PMID: 35050483
Palmer SC, Mavridis D, Johnson DW, Tonelli M, Ruospo M, Strippoli GFM
Am J Kidney Dis 2020 Sep;76(3):321-330. Epub 2020 May 28 doi: 10.1053/j.ajkd.2020.02.439. PMID: 32475604
Ahmadmehrabi S, Tang WHW
Semin Dial 2018 May;31(3):258-267. Epub 2018 Apr 6 doi: 10.1111/sdi.12694. PMID: 29624739Free PMC Article
Vulpio C, Bossola M
Semin Dial 2016 Sep;29(5):347-9. Epub 2016 Jul 15 doi: 10.1111/sdi.12521. PMID: 27419923
Fraser WD
Lancet 2009 Jul 11;374(9684):145-58. doi: 10.1016/S0140-6736(09)60507-9. PMID: 19595349

Clinical prediction guides

Shigematsu T, Koiwa F, Isaka Y, Fukagawa M, Hagita K, Watanabe YS, Honda D, Akizawa T
Clin J Am Soc Nephrol 2023 Oct 1;18(10):1300-1309. Epub 2023 Sep 11 doi: 10.2215/CJN.0000000000000253. PMID: 37696667Free PMC Article
Komaba H, Hamano T, Fujii N, Moriwaki K, Wada A, Masakane I, Nitta K, Fukagawa M
J Clin Endocrinol Metab 2022 Jun 16;107(7):2016-2025. doi: 10.1210/clinem/dgac142. PMID: 35277957
Lau WL, Obi Y, Kalantar-Zadeh K
Clin J Am Soc Nephrol 2018 Jun 7;13(6):952-961. Epub 2018 Mar 9 doi: 10.2215/CJN.10390917. PMID: 29523679Free PMC Article
Komaba H, Fukagawa M
Semin Dial 2015 Nov-Dec;28(6):594-603. Epub 2015 Aug 12 doi: 10.1111/sdi.12413. PMID: 26265359
Duan K, Gomez Hernandez K, Mete O
J Clin Pathol 2015 Oct;68(10):771-87. Epub 2015 Jul 10 doi: 10.1136/jclinpath-2015-203186. PMID: 26163537

Recent systematic reviews

Li X, Ding W, Zhang H
Front Endocrinol (Lausanne) 2023;14:1146955. Epub 2023 Jul 19 doi: 10.3389/fendo.2023.1146955. PMID: 37538795Free PMC Article
Wang A, Wang Y, Liu H, Hu X, Li J, Xu H, Nie Z, Zhang L, Lyu Z
Front Endocrinol (Lausanne) 2022;13:1027841. Epub 2022 Oct 31 doi: 10.3389/fendo.2022.1027841. PMID: 36387892Free PMC Article
Liu Y, Yang Q, Chen G, Zhou T
Curr Pharm Des 2022;28(40):3289-3304. doi: 10.2174/1381612829666221027110656. PMID: 36305135
Zhou X, Shen Y, Zhu Y, Lv Q, Pu W, Gao L, Gu M, Li C
Int J Hyperthermia 2021;38(1):1285-1294. doi: 10.1080/02656736.2021.1965664. PMID: 34428994
Palmer SC, Mavridis D, Johnson DW, Tonelli M, Ruospo M, Strippoli GFM
Am J Kidney Dis 2020 Sep;76(3):321-330. Epub 2020 May 28 doi: 10.1053/j.ajkd.2020.02.439. PMID: 32475604

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...